I-MAB

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell I-MAB and other ETFs, options, and stocks.

About IMAB

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Pudong, China. 

CEO
Jing Wu Zang
CEOJing Wu Zang
Employees
378
Employees378
Headquarters
Pudong, Shanghai
HeadquartersPudong, Shanghai
Founded
2016
Founded2016
Employees
378
Employees378

IMAB Key Statistics

Market cap
326.58M
Market cap326.58M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
427.19K
Average volume427.19K
High today
$4.04
High today$4.04
Low today
$3.80
Low today$3.80
Open price
$4.04
Open price$4.04
Volume
450.88K
Volume450.88K
52 Week high
$74.59
52 Week high$74.59
52 Week low
$3.80
52 Week low$3.80

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

IMAB Earnings

Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Estimated per share
Actual
Available Aug 30, Pre-Market
ActualAvailable Aug 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.